Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
[Oculomotor system and multiple sclerosis.]
Does antiretroviral therapy for HIV reduce the risk of developing multiple sclerosis?
Immunological and pathological characterization of fatal rebound MS activity following natalizumab withdrawal.
Cardiovascular adaptation in people with multiple sclerosis following a twelve week exercise programme suggest deconditioning rather than autonomic dysfunction caused by the disease Results from a randomized controlled trial.
Bilateral Optic Neuritis due to Malaria.
Transient autoimmune hyperthyroidism following the withdrawal of Natalizumab in patients with multiple sclerosis.
Translation, cross-cultural adaptation and validation of the Portuguese version of the DYMUS questionnaire for the assessment of dysphagia in multiple sclerosis.
Identifying Symptom Co-Occurrence in Persons With Multiple Sclerosis.
Aberrant Type I Interferon Regulation in Autoimmunity: Opposite Directions in MS and SLE, Shaped by Evolution and Body Ecology.
Circulating CD56(dim) NK cells expressing perforin are increased in progressive multiple sclerosis.
Plasmablasts as Migratory IgG-Producing Cells in the Pathogenesis of Neuromyelitis Optica.
Abnormal distribution of AQP5 in labial salivary glands is associated with poor saliva secretion in patients with Sjögren's syndrome including neuromyelitis optica complicated patients.
Oligodendrogenesis in the fornix of adult mouse brain; the effect of LPS-induced inflammatory stimulation.
Gelsolin decreases actin toxicity and inflammation in murine multiple sclerosis.
Cytokine-Defined B Cell Responses as Therapeutic Targets in Multiple Sclerosis.
Heme oxygenase-1 is dispensable for the anti-inflammatory activity of intravenous immunoglobulin.
Systematic review versus internet search: considerations about availability and reliability of medical information regarding pregnancy in women with multiple sclerosis.
A 62-Year-Old Man With Fluctuating Neurological Deficits and Skin Lesions.
Localized grey matter atrophy in multiple sclerosis: A meta-analysis of voxel-based morphometry studies and associations with functional disability.
Bone turnover and metabolism in patients with early multiple sclerosis and prevalent bone mass deficit: a population-based case-control study.
Immunopathology of multiple sclerosis.
Central neuropathic pain in MS is due to distinct thoracic spinal cord lesions.
Mesenchymal stem cells do not exert direct beneficial effects on CNS remyelination in the absence of the peripheral immune system.
The Primate EAE Model Points at EBV-Infected B Cells as a Preferential Therapy Target in Multiple Sclerosis.
Ultra-high field MRI: looking through the 'macroscope'
Pages
« first
‹ previous
…
532
533
534
535
536
537
538
539
540
…
next ›
last »